186 related articles for article (PubMed ID: 9720)
1. [A practical guide for the use of psychopharmacologic agents. II. Antipsychotic and antiparkinson agents].
Chouinard G
Union Med Can; 1976 Sep; 105(9):1387-97. PubMed ID: 9720
[No Abstract] [Full Text] [Related]
2. Drug treatment of schizophrenia.
Hollister LE
Psychiatr Clin North Am; 1984 Sep; 7(3):435-52. PubMed ID: 6148741
[TBL] [Abstract][Full Text] [Related]
3. [Neuroleptics in children].
Daléry J; Beaufrère B; Maillet J; de Villard R
Pediatrie; 1980; 35(1):89-94. PubMed ID: 6102756
[No Abstract] [Full Text] [Related]
4. [On application of antipsychotic drugs].
Shimizu M
No To Shinkei; 1994 Mar; 46(3):209-14. PubMed ID: 7910750
[No Abstract] [Full Text] [Related]
5. Antipsychotic drugs--an update.
Charalampous KD; Keepers GA
J Okla State Med Assoc; 1978 Jan; 71(1):6-9. PubMed ID: 23420
[No Abstract] [Full Text] [Related]
6. Use of quetiapine in elderly patients.
Tariot PN; Ismail MS
J Clin Psychiatry; 2002; 63 Suppl 13():21-6. PubMed ID: 12562143
[TBL] [Abstract][Full Text] [Related]
7. Schizophrenia.
Kane JM
N Engl J Med; 1996 Jan; 334(1):34-41. PubMed ID: 7494570
[No Abstract] [Full Text] [Related]
8. Extrapyramidal reactions in adolescents treated with high-potency antipsychotics.
Chiles JA
Am J Psychiatry; 1978 Feb; 135(2):239-40. PubMed ID: 23686
[No Abstract] [Full Text] [Related]
9. Pathophysiology of antipsychotic drug-induced movement disorders.
Casey DE
J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
[TBL] [Abstract][Full Text] [Related]
10. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
Sramek JJ; Simpson GM; Morrison RL; Heiser JF
J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
[TBL] [Abstract][Full Text] [Related]
11. Akinesia and postpsychotic depression: a difficult differential diagnosis.
Siris SG
J Clin Psychiatry; 1987 Jun; 48(6):240-3. PubMed ID: 2884213
[TBL] [Abstract][Full Text] [Related]
12. [Current status of our knowledge of the neurotropic side effects of neuroleptic drugs].
Sabbatini F; Pinessi L; Gentile S; De Mattei M; Portaleone P
Minerva Psichiatr; 1983; 24(4):145-53. PubMed ID: 6145083
[No Abstract] [Full Text] [Related]
13. Medical and legal implications of side effects from neuroleptic drugs. A round-table discussion.
Cancro R; Davis JM; Klawans H; Tancredi L
J Clin Psychiatry; 1981 Feb; 42(2):78-82. PubMed ID: 6109720
[TBL] [Abstract][Full Text] [Related]
14. Unwanted effects of psychotrophic drugs. II.--Drugs for schizophrenia.
Edwards JG
Practitioner; 1977 May; 218(1307):696-700. PubMed ID: 18729
[No Abstract] [Full Text] [Related]
15. [Antipsychotic neuroplegic and neuroleptic agents. IV. Phenothiazines (3)].
Deligné P; Bunodière M
Ann Anesthesiol Fr; 1978; 19(9):1J-13J. PubMed ID: 32805
[No Abstract] [Full Text] [Related]
16. Use of antipsychotic medication in the elderly.
Maletta GJ
Annu Rev Gerontol Geriatr; 1984; 4():175-220. PubMed ID: 6152711
[No Abstract] [Full Text] [Related]
17. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
Salvesen C; Vaksdal K
Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740
[No Abstract] [Full Text] [Related]
18. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Cesková E; Svestka J
Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
[TBL] [Abstract][Full Text] [Related]
19. Practical considerations in the use of depot neuroleptics for the treatment of schizophrenia.
Johnson DA
Br J Hosp Med; 1977 Jun; 17(6):546-58. PubMed ID: 18242
[No Abstract] [Full Text] [Related]
20. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
Dencker SJ
J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
